Frédéric Grimaud
President bij Grimaud Vietnam Co. Ltd.
Vermogen: 1 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van Frédéric Grimaud
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
34
| Public Company | Biotechnology | 34 |
Vivalis SA
 Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France.
11
| Extinct | Pharmaceuticals: Other | 11 |
Intercell Austria AG
3
| Private Company | 3 | |
Chengdu Grimaud Breeding Co. Ltd.
1
| Private Company | 1 | |
Grimaud Frères Holding SASU
 Grimaud Frères Holding SASU Financial ConglomeratesFinance Grimaud Frères Holding SASU is an investment holding private company based in Sevremoine, France. and has subsidiaries in China. Grimaud Frères Holding SASU functions as an investment holding French company. The company was founded in 2014, and Yann Le Pottier has been the CEO of the company since 2014.
1
| Private Company | Financial Conglomerates | 1 |
Filavie SAS
 Filavie SAS Pharmaceuticals: MajorHealth Technology Filavie SAS manufactures pharmaceutical products. The private company is based in Roussay, France.
1
| Private Company | Pharmaceuticals: Major | 1 |
Grimaud Deyang Animal Co. Ltd.
1
| Private Company | 1 | |
Choice Genetics USA LLC
 Choice Genetics USA LLC BiotechnologyHealth Technology Choice Genetics USA LLC produces swine genetics products. Its products include EXM, P26, CG32 and EBX. The company is headquartered in West Des Moines, IA.
1
| Subsidiary | Biotechnology | 1 |
Blue Genetics Mexico
 Blue Genetics Mexico Miscellaneous Commercial ServicesCommercial Services Blue Genetics Mexico is a Mexican global company that specializes in the selection of shrimp genetics and supplies high-quality shrimp broodstock that is specific pathogen-free (SPF). Blue Genetics Mexico is based in La Paz, Mexico. The private company is a subsidiary of Groupe Grimaud. The CEO of the company is Carlos Alberto Pineda.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Grimaud Frères Sélection SAS
 Grimaud Frères Sélection SAS Agricultural Commodities/MillingProcess Industries Grimaud Frères Sélection SAS is a poultry firm. Its products include mule, muscovy, pekin ducks, gesse and pigeons. The company was founded in 1995 and is headquartered in Sevremoine, France.
1
| Subsidiary | Agricultural Commodities/Milling | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Frédéric Grimaud via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ORANGE | Wireless Telecommunications | Director/Board Member | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| EUTELSAT COMMUNICATIONS | Major Telecommunications | Director/Board Member | |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| POXEL | Pharmaceuticals: Major | Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree Masters Business Admin | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member Director/Board Member | |
| SOITEC | Electronic Components | Director/Board Member | |
Groupe Limagrain Holding SA
 Groupe Limagrain Holding SA Agricultural Commodities/MillingProcess Industries Groupe Limagrain Holding SA engages in agricultural production. It offers wheat, corn, maize, sunflower, rapeseed, tomato, carrot, melon, cauliflower, and pepper, as well as flower seeds. The company was founded in 1965 and is headquartered in Saint-Beauzire, France. | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree | |
| Karolinska Institutet | College/University | Chairman Chairman | |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
Groupe Grimaud La Corbière SA
 Groupe Grimaud La Corbière SA BiotechnologyHealth Technology Groupe Grimaud La Corbière SA specializes in biopharmaceutical and animal genetic solutions. It operates under two segments: Genetic Selection and sale of animal breeders such as broiler, and layer chickens, pigs, ducks, guinea, fowl, rabbits and pigeons; while Biopharmacy serves human and animal health such as vaccines, pharmaceutical proteins and serums for specific pathogen. The company was founded in 1966 and is headquartered in Roussay, France. | Biotechnology | Chairman Director/Board Member | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VERIMATRIX | Semiconductors | Director/Board Member | |
| École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin Undergraduate Degree | |
| University of Strasbourg | College/University | Doctorate Degree Undergraduate Degree | |
Crystal SA (Chatillon)
 Crystal SA (Chatillon) Other Consumer ServicesConsumer Services Crystal SA provides construction and renovation services. The company was founded in 1996 and is headquartered in Châtillon, France. | Other Consumer Services | Director/Board Member | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Analyst Private Equity Analyst | |
Novasep Holding SAS
 Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France. | Chemicals: Major Diversified | Director/Board Member Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Nice Sophia Antipolis | College/University | Doctorate Degree | |
| VEXIM | Medical Specialties | Director/Board Member | |
Dassiet Oy
 Dassiet Oy Medical SpecialtiesHealth Technology Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland. | Medical Specialties | Director/Board Member Director/Board Member | |
Bpifrance Participations SA /PRIVATE EQUITY/
 Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Tyrol Acquisition 1 SARL
 Tyrol Acquisition 1 SARL MiscellaneousMiscellaneous Part of TDF SAS, Tyrol Acquisition 1 SARL operates as a holding Luxembourger company. | Miscellaneous | Director/Board Member | |
Valneva Scotland Ltd.
 Valneva Scotland Ltd. BiotechnologyHealth Technology Part of Valneva SE, Valneva Scotland Ltd. is a British vaccine company that specializes in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The private company is based in Livingston, UK. The company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and chikungunya. Valneva's portfolio also includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Gruau SA /Gruau/
 Gruau SA /Gruau/ Financial ConglomeratesFinance Gruau SA is a private group led by Patrick Gruau. | Financial Conglomerates | Director/Board Member | |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Biotechnology | Corporate Officer/Principal | |
| Smol Therapeutics SAS | Chief Executive Officer Chairman | ||
| Vivalis Toyama Japan KK | Chairman Director/Board Member | ||
Valneva Austria GmbH
 Valneva Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Valneva SE, VALNEVA Austria GmbH is an Austrian biotechnology company that develops and commercializes vaccines for infectious diseases. The private company is based in Vienna, Austria. The CEOs are Thomas Lingelbach, Franck Charles Marie Grimaud, Frédéric Jacotot. The company was founded in 2013. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
| Elatos GmbH | Chief Executive Officer Corporate Officer/Principal | ||
Vaccines Holdings Sweden AB
 Vaccines Holdings Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Vaccines Holdings Sweden AB develops and distributes vaccines and biological products. The private company is based in Solna, Sweden. Franck Charles Marie Grimaud has been the CEO of the Swedish company since 2014. | Biotechnology | Director/Board Member Chief Executive Officer Chairman Director/Board Member Director/Board Member | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
BliNK Biomedical SAS
 BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | Biotechnology | Director/Board Member Director/Board Member | |
Valneva Sweden AB
 Valneva Sweden AB BiotechnologyHealth Technology Part of Valneva SE, Valneva Sweden AB is a specialty vaccine company that focuses on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The private company is based in Solna, Sweden and is primarily focused on marketing and distributing Valneva's vaccines Dukoral®, Ixiaro®, and Kamrab™. Valneva has several vaccines in development, including unique vaccines against Lyme disease, COVID-19, and Chikungunya. Additionally, Valneva's portfolio includes two commercial vaccines for travelers. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
| EXICURE, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Valneva UK Ltd.
 Valneva UK Ltd. Medical/Nursing ServicesHealth Services Part of Valneva SE, Valneva UK Ltd. provides health care services. The private company is based in London, UK and was founded in 2015. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Valneva Canada, Inc.
 Valneva Canada, Inc. Medical DistributorsDistribution Services Part of Valneva SE, Valneva Canada, Inc. engages in marketing and distribution of vaccines. The private company is based in Kirkland, Canada. | Medical Distributors | Director/Board Member President Director/Board Member | |
Meininger Verlag GmbH
 Meininger Verlag GmbH Publishing: Books/MagazinesConsumer Services Meininger Verlag GmbH provides the latest news and tasting results from the wine and beverage industry. The private company is based in Neustadt, Germany. The German company offers information on the best wines, beers, and spirits. The CEOs are Wolfgang Heckmann, Horst Emmert, Ralf Clemens. The company was founded in 1903 by Daniel Meininger. | Publishing: Books/Magazines | Chief Executive Officer | |
| Valneva USA, Inc. | Director/Board Member Chief Executive Officer Chief Executive Officer |
Statistieken
Internationaal
| Frankrijk | 23 |
| Verenigde Staten | 11 |
| Verenigd Koninkrijk | 7 |
| Zweden | 5 |
| Oostenrijk | 4 |
Sectoraal
| Health Technology | 22 |
| Consumer Services | 9 |
| Commercial Services | 5 |
| Finance | 5 |
| Communications | 3 |
Operationeel
| Director/Board Member | 276 |
| Corporate Officer/Principal | 86 |
| Independent Dir/Board Member | 45 |
| Chief Executive Officer | 40 |
| Director of Finance/CFO | 37 |
Sterkste connecties
| Insiders | |
|---|---|
| Anne-Sophie Herelle | 64 |
| Alain Munoz | 38 |
| Hans Lennart Rudolf Wigzell | 30 |
| David Lawrence | 29 |
| Michel Gréco | 28 |
| James Sulat | 23 |
| Anne-Marie Graffin | 22 |
| Franck Grimaud | 22 |
| Maïlys Ferrère | 21 |
| Sharon Tetlow | 21 |
| Bali Muralidhar | 19 |
| Thomas Casdagli | 18 |
| Thomas Lingelbach | 17 |
| Ralf Clemens | 14 |
| Peter Buhler | 14 |
- Beurs
- Insiders
- Frédéric Grimaud
- Bedrijfsconnecties
